Source: Eur Respir J 2014; 44: 382-393
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Brodt Alessandra Monteiro, Stovold Elizabeth, Zhang Linjie. Inhaled antibiotics for stable non-cystic fibrosis bronchiectasis: a systematic review. Eur Respir J 2014; 44: 382-393

Member's Comments

No comment yet.

Related content which might interest you: Inhaled antibiotics in non-cystic fibrosis bronchiectasis: better than oral antibiotics? Source: International Congress 2016 – PG13 Inhaled antibiotics in respiratory infections Year: 2016 Prescription of Inhaled corticosteroid in non-cystic fibrosis bronchiectasis:a solution or a problem Source: Virtual Congress 2020 – News on clinical evaluation of bronchiectasis, cough and inflammatory disease Year: 2020 Inhaled steroids in children with non-cystic fibrosis bronchiectasis Source: Eur Respir J 2004; 24: Suppl. 48, 392s Year: 2004 Inhaled bronchodilators in cystic fibrosis: a Cochrane review Source: Annual Congress 2006 - Cystic fibrosis lung disease: molecules images and drugs Year: 2006 Inhaled antimicrobials Source: ERS webinar 2020: Inhaled antimicrobials Year: 2020 Aerozolized colistin therapy in non-cystic fibrosis patients with bronchiectasis Source: Eur Respir J 2001; 18: Suppl. 33, 266s Year: 2001 Inhaled antibiotics in cystic fibrosis: what we should do and what we still do not know Source: International Congress 2016 – PG13 Inhaled antibiotics in respiratory infections Year: 2016 Effects of long-term azithromycin treatment in patients with non-cystic fibrosis stable bronchiectasis Source: Annual Congress 2007 - Infectious lung and pleural diseases Year: 2007 Inhaled colistin following lung transplantation in colonised cystic fibrosis patients Source: Eur Respir J 2013; 42: 542-544 Year: 2013 The clinical efficacy of pulmonary hypertension-specific agents in idiopathic pulmonary fibrosis: A systematic review and meta-analysis Source: International Congress 2019 – Treatment and prognosis of idiopathic interstitial pneumonia Year: 2019 Efficacy and safety of inhaled antibiotics for chronic pseudomonas infection in cystic fibrosis: Network meta-analysis Source: International Congress 2016 – Cystic fibrosis: inflammation, microbiology, management and monitoring Year: 2016 Prolonged antibiotics for non-cystic fibrosis purulent bronchiectasis in children and adults: A Cochrane review Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options Year: 2014 Retrospective analysis of CT before and after azithromycin therapy in non-cystic fibrosis bronchiectasis using a modified Brody-score Source: Annual Congress 2010 - From rare towards common lung diseases: diagnostic and monitoring challenges Year: 2010 Adherence with inhaled colistimethate sodium during a 6 month study in patients with non-cystic fibrosis bronchiectasis Source: Annual Congress 2013 –Treating bronchiectasis in respiratory patients Year: 2013 Knowledge and adherence of airway clearance techniques in patients with non-cystic fibrosis bronchiectasis Source: International Congress 2015 – Respiratory physiotherapy: outcomes in disease and health Year: 2015 Non-cystic fibrosis bronchiectasis: series of 89 patients Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD Year: 2008 Resistance to antimicrobial agents in patients with non-cystic fibrosis (CF) bronchiectasis Source: Eur Respir J 2005; 26: Suppl. 49, 640s Year: 2005